Adamis Pharmaceuticals Corp (ADMP)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Adamis Pharmaceuticals Corp (ADMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011820
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. Adamis also provides pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-3000, an HFA inhaled nasal steroid product for the treatment of allergic rhinitis. The company provides its products for patients, physicians, and healthcare organizations. It has operations in Phoenix, Arizona. Adamis is headquartered in San Diego, California, the US.

Adamis Pharmaceuticals Corp (ADMP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2011 to YTD 2017 9
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 11
Equity Offering 13
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 13
Adamis Pharma Raises USD11 Million in Private Placement of Units 15
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 18
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 19
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 21
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 22
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For US$0.5 Million 23
Debt Offering 24
Adamis Pharma Completes Private Placement Of Debentures For US$0.6 Million 24
Adamis Pharma Completes Private Placement Of Senior Convertible Note For US$0.5 Million 25
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For US$1 Million 26
Adamis Pharmaceuticals Corp – Key Competitors 27
Adamis Pharmaceuticals Corp – Key Employees 28
Adamis Pharmaceuticals Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adamis Pharmaceuticals Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Adamis Pharmaceuticals Corp, Medical Devices Deals, 2011 to YTD 2017 9
Adamis Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 11
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 13
Adamis Pharma Raises USD11 Million in Private Placement of Units 15
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 17
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 18
Adamis Pharma Raises USD11.5 Million in Public Offering of Shares 19
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 21
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 22
Adamis Pharma Completes Final Tranche Of Private Placement Of Shares For US$0.5 Million 23
Adamis Pharma Completes Private Placement Of Debentures For US$0.6 Million 24
Adamis Pharma Completes Private Placement Of Senior Convertible Note For US$0.5 Million 25
Adamis Pharma Completes Private Placement Of Senior Convertible Note Due 2013 For US$1 Million 26
Adamis Pharmaceuticals Corp, Key Competitors 27
Adamis Pharmaceuticals Corp, Key Employees 28
Adamis Pharmaceuticals Corp, Subsidiaries 29

★海外企業調査レポート[Adamis Pharmaceuticals Corp (ADMP)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gameloft SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gameloft SA Mergers and Acquisi …
  • Molecular Targeting Technologies, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Molecular Targeting Technologies Inc. (MTTI) is a biotechnology company. The company develops medical imaging products for the diagnosis and treatment of cardiovascular disease and cancer. Its products include cellvue, psvue, neurovue, srflour, lipophilic cyanines, immobilized steroid beads, …
  • Huntsworth plc (HNT):企業の財務及び戦略的SWOT分析
    Summary Huntsworth plc (Huntsworth) is a business consumer company that offers consultancy services. The company provides public relations and integrated healthcare communication services to its clients. It operates through four segments such as citigate, grayling, huntsworth health and red. Huntswo …
  • Odyssey Thera, inc.(製薬・医療分野):企業M&A動向
    Summary Odyssey Thera, inc. (Odyssey Thera) is a drug discovery company. The company develops cellular pharmacology strategy for the identification of medicines for a range of human diseases. Its product pipeline includes novel small molecule inhibitors that block key signaling nodes in human cancer …
  • New York Power Authority:戦略・SWOT・企業財務分析
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Silver Wheaton Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Silver Wheaton Corp. Mergers an …
  • Resolute Forest Products Inc.:企業のM&A・提携・投資分析
    Resolute Forest Products Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Resolute Forest Products Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Kyowa Kirin International plc:企業のM&A・提携・投資分析
    Kyowa Kirin International plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kyowa Kirin International plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Lupatech S.A. (LUPA3):企業財務及び戦略的SWOT分析
    Summary Lupatech S.A. (Lupatech) is an oil and gas company that offers equipment supply and consulting services. The company offers products such as polyster ropes, oil and gas valves, special pipe lining, gas compressors, fiber optic monitoring systems, and others. Its services comprise tubular ser …
  • Medical Transcription Billing Corp (MTBC):企業財務及び戦略的SWOT分析
    Summary Medical Transcription Billing, Corp. (Medical Transcription) is a healthcare information technology (IT) company that provides web-based solutions and related business services. The company’s products include ChartsPro, a web-based electronic health records system; PracticePro, a practice ma …
  • Lavendon Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lavendon Group plc Mergers and …
  • Mattel, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mattel, Inc. Mergers and Acquis …
  • Burmeister & Wain Scandinavian Contractor AS:企業のM&A・提携動向(発電分野)
    Summary Burmeister & Wain Scandinavian Contractor A/S (BWSC), a subsidiary of MESCO Denmark A/S, is a provider of tailor-made turnkey power plant solutions. It develops, operates and undertakes contracts for medium to large-scale power plants. The company handles projects for conventional fossil-fue …
  • Otokar Otobus Karoseri Sanayi ASの企業概要及び財務/SWOT分析
    Otokar Otobus Karoseri Sanayi AS Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Otokar Otobus Karoseri Sanayi AS annual and quarterly forecasts made by stock market experts. …
  • Prototype Productions, Inc.:企業の戦略・SWOT・財務分析
    SummaryPrototype Productions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Hudson Pacific Properties Inc.:企業のM&A・提携・投資分析
    Hudson Pacific Properties Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hudson Pacific Properties Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Turkiye Garanti Bankasi A.S.:企業の戦略・SWOT・財務分析
    SummaryTurkiye Garanti Bankasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Cia Iguacu de Cafe Soluvel:企業の戦略・SWOT・財務分析
    SummaryCia Iguacu de Cafe Soluvel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Align Technology, Inc. (ALGN):企業のM&A・提携動向(医療機器分野)
    Summary Align Technology, Inc. (Align) offers products and solutions that improve the treatment efficiencies of the dental therapies. Its product and service offerings include a system of clear aligner therapy, intra-oral scanners, and computer-aided design, and computer-aided manufacturing (CAD/CAM …
  • Gilead Sciences Inc (GILD):企業のM&A・提携動向(医療機器分野)
    Summary Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative medicines for diseases with unmet medical need. The company offers products in various therapeutic areas including cardiovascular, respirat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆